techgroup header image Cell Line for Production of Recombinant Human Tissue Inhibitor of Metalloproteinase-2

therapoid
Provided by: National Institutes of Health (NIH)
Tags: TIMP-2 Tumor Suppressor Myocardial Infarct Ischemic Diseases Neurodegenerative Diseases HEK-293F cell line cancer
techgroup
Short Description:

This technology envelops a unique HEK-293F cell line which stably expresses rhTIMP-2, increasing the production of TIMP-2 to quantities sufficient for testing and developing therapies.